PHARMACYTE BIOTECH INC's ticker is PMCBD and the CUSIP is 71715X203. A total of 32 filers reported holding PHARMACYTE BIOTECH INC in Q4 2022. The put-call ratio across all filers is 1.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,494 | -50.2% | 19,283 | -32.1% | 0.00% | – |
| Q2 2023 | $81,267 | -4.5% | 28,415 | -2.8% | 0.00% | – |
| Q1 2023 | $85,112 | -22.8% | 29,248 | -22.3% | 0.00% | – |
| Q4 2022 | $110,224 | +22.5% | 37,619 | -0.0% | 0.00% | – |
| Q3 2022 | $90,000 | +7.1% | 37,630 | 0.0% | 0.00% | – |
| Q2 2022 | $84,000 | +2.4% | 37,630 | +5.6% | 0.00% | – |
| Q1 2022 | $82,000 | -7.9% | 35,641 | +0.5% | 0.00% | – |
| Q4 2021 | $89,000 | – | 35,456 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayrton Capital LLC | 92,087 | $193,383 | 1.31% |
| SABBY MANAGEMENT, LLC | 97,124 | $203,960 | 0.15% |
| K2 PRINCIPAL FUND, L.P. | 258,481 | $542,810 | 0.11% |
| EQUITEC PROPRIETARY MARKETS, LLC | 82,727 | $173,727 | 0.04% |
| CSS LLC/IL | 13,186 | $27,691 | 0.00% |
| Aspire Private Capital, LLC | 800 | $1,680 | 0.00% |
| Schonfeld Strategic Advisors LLC | 23,300 | $48,930 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,971 | $4,139 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 29,307 | $61,545 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 116 | $243 | 0.00% |